Skip to main content

Table 2 Descriptive analysis of corporate governance statements for 2014–2018 period

From: Public health and corporate social responsibility: exploratory study on pharmaceutical companies in an emerging market

Analyzed company Fully/Partially/Non-Implemented Requirements Calculated conformity rate (%)
Implemented Partially Non- N/A
Nr. (%) Nr. (%) Nr. (%) Nr. (%)
A 41 100,00 0 0,00 0 0,00 0 0,00 100
B 23 56,10 5 12,20 13 31,71 0 0,00 47,5
C 40 97,56 1 2,44 0 0,00 0 0,00 95
D 39 95,12 0 0,00 1 2,44 1 2,44 100
E 38 92,68 0 0,00 2 4,88 1 2,44 99
F 25 60,98 7 17,07 8 19,51 1 2,44 66,8
TOTAL 209 13 24 3
Pharmaceutical industry means 33,60 80,49 2,60 6,34 4,80 11,71 0,60 1,46 84,72
  1. Source: authors’ own research and projections based on annual reports published on BSE [43].